Predictive Oncology Current Ratio 2010-2025 | POAI
Predictive Oncology current ratio from 2010 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Predictive Oncology Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2025-03-31 | $0.00B | $0.01B | 0.76 |
| 2024-12-31 | $0.00B | $0.00B | 0.62 |
| 2024-09-30 | $0.01B | $0.00B | 1.20 |
| 2024-06-30 | $0.01B | $0.01B | 1.49 |
| 2024-03-31 | $0.01B | $0.01B | 1.45 |
| 2023-12-31 | $0.01B | $0.00B | 2.55 |
| 2023-09-30 | $0.01B | $0.00B | 3.24 |
| 2023-06-30 | $0.02B | $0.00B | 4.24 |
| 2023-03-31 | $0.02B | $0.00B | 5.06 |
| 2022-12-31 | $0.02B | $0.00B | 6.02 |
| 2022-09-30 | $0.03B | $0.00B | 7.74 |
| 2022-06-30 | $0.03B | $0.00B | 10.56 |
| 2022-03-31 | $0.03B | $0.00B | 9.79 |
| 2021-12-31 | $0.03B | $0.00B | 9.09 |
| 2021-09-30 | $0.04B | $0.00B | 14.42 |
| 2021-06-30 | $0.05B | $0.00B | 14.16 |
| 2021-03-31 | $0.03B | $0.00B | 8.65 |
| 2020-12-31 | $0.00B | $0.01B | 0.16 |
| 2020-09-30 | $0.00B | $0.01B | 0.30 |
| 2020-06-30 | $0.00B | $0.02B | 0.30 |
| 2020-03-31 | $0.00B | $0.01B | 0.30 |
| 2019-12-31 | $0.00B | $0.01B | 0.07 |
| 2019-09-30 | $0.00B | $0.01B | 0.10 |
| 2019-06-30 | $0.00B | $0.01B | 0.12 |
| 2019-03-31 | $0.00B | $0.01B | 0.77 |
| 2018-12-31 | $0.00B | $0.00B | 0.40 |
| 2018-09-30 | $0.00B | $0.00B | 1.30 |
| 2018-06-30 | $0.00B | $0.00B | 3.14 |
| 2018-03-31 | $0.00B | $0.00B | 3.99 |
| 2017-12-31 | $0.00B | $0.00B | 2.54 |
| 2017-09-30 | $0.00B | $0.00B | 2.71 |
| 2017-06-30 | $0.00B | $0.00B | 3.45 |
| 2017-03-31 | $0.01B | $0.00B | 4.06 |
| 2016-12-31 | $0.00B | $0.00B | 1.66 |
| 2016-09-30 | $0.00B | $0.00B | 1.16 |
| 2016-06-30 | $0.00B | $0.00B | 1.72 |
| 2016-03-31 | $0.00B | $0.00B | 2.51 |
| 2015-12-31 | $0.01B | $0.00B | 3.55 |
| 2015-09-30 | $0.01B | $0.00B | 3.15 |
| 2015-06-30 | $0.00B | $0.01B | 0.08 |
| 2015-03-31 | $0.00B | $0.01B | 0.08 |
| 2014-12-31 | $0.00B | $0.01B | 0.10 |
| 2014-09-30 | $0.00B | $0.01B | 0.20 |
| 2014-06-30 | $0.00B | $0.00B | 0.18 |
| 2014-03-31 | $0.00B | $0.00B | 0.30 |
| 2013-12-31 | $0.00B | $0.00B | 0.11 |
| 2013-09-30 | $0.00B | $0.00B | 0.40 |
| 2013-06-30 | $0.00B | $0.00B | 0.11 |
| 2013-03-31 | $0.00B | $0.00B | 0.22 |
| 2012-12-31 | $0.00B | $0.00B | 0.07 |
| 2012-09-30 | $0.00B | $0.00B | 0.12 |
| 2012-06-30 | $0.00B | $0.00B | 0.09 |
| 2012-03-31 | $0.00B | $0.00B | 0.08 |
| 2011-12-31 | $0.00B | $0.00B | 0.13 |
| 2011-09-30 | $0.00B | $0.00B | 0.07 |
| 2011-06-30 | $0.00B | $0.00B | 0.05 |
| 2011-03-31 | $0.00B | $0.00B | 0.19 |
| 2010-12-31 | $0.00B | $0.00B | 0.01 |
| 2010-09-30 | $0.00B | $0.00B | 0.02 |
| 2010-06-30 | $0.00B | $0.00B | 0.04 |
| 2010-03-31 | $0.00B | $0.00B | 0.07 |
| 2009-12-31 | $0.00B | $0.00B | 0.10 |
| 2009-09-30 | $0.00B | $0.00B | 0.17 |
| 2009-06-30 | $0.00B | 0.00 | |
| 2009-03-31 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.008B | $0.002B |
| Predictive Oncology Inc. is focused on applying artificial intelligence to personalized medicine and drug discovery. Its operating business unit consists of Helomics, TumorGenesis and Skyline Medical. Predictive Oncology Inc., formerly known as Precision Therapeutics Inc., is based in MINNEAPOLIS. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.994B | 58.52 |
| Hims & Hers Health (HIMS) | United States | $12.427B | 102.82 |
| Doximity (DOCS) | United States | $10.881B | 50.37 |
| Tempus AI (TEM) | United States | $9.996B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $5.151B | 0.00 |
| Hinge Health (HNGE) | United States | $3.762B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.600B | 38.22 |
| Privia Health (PRVA) | United States | $2.371B | 162.08 |
| 10x Genomics (TXG) | United States | $1.639B | 0.00 |
| Phreesia (PHR) | United States | $1.613B | 0.00 |
| Enovis (ENOV) | United States | $1.511B | 8.43 |
| Clover Health Investments (CLOV) | United States | $1.450B | 0.00 |
| Schrodinger (SDGR) | United States | $1.441B | 0.00 |
| Omnicell (OMCL) | United States | $1.429B | 26.99 |
| Azenta (AZTA) | United States | $1.231B | 53.80 |
| Evolent Health (EVH) | United States | $1.115B | 95.00 |
| Claritev (CTEV) | United States | $0.650B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.636B | 0.00 |
| Veradigm (MDRX) | United States | $0.514B | 0.00 |
| Standard BioTools (LAB) | United States | $0.494B | 0.00 |
| Talkspace (TALK) | United States | $0.380B | 113.50 |
| Zepp Health (ZEPP) | Netherlands | $0.349B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.336B | 0.00 |
| Carlsmed (CARL) | $0.325B | 0.00 | |
| TruBridge (TBRG) | United States | $0.314B | 696.33 |
| Health Catalyst (HCAT) | United States | $0.266B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.254B | 0.00 |
| Outset Medical (OM) | United States | $0.250B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.228B | 0.00 |
| CapsoVision (CV) | United States | $0.192B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.151B | 0.00 |
| American Well (AMWL) | United States | $0.132B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.118B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.113B | 0.00 |
| CareCloud (CCLD) | United States | $0.101B | 4.58 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.084B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.075B | 0.00 |
| Pulmonx (LUNG) | United States | $0.067B | 0.00 |
| 111 (YI) | China | $0.059B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.050B | 0.00 |
| HeartBeam (BEAT) | United States | $0.034B | 0.00 |
| Zhongchao (ZCMD) | China | $0.024B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.013B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.007B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.007B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.005B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| PROFUSA (PFSA) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |